These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16379409)

  • 1. Model-based evaluation of diabetic foot prevention strategies in Austria.
    Rauner MS; Heidenberger K; Pesendorfer EM
    Health Care Manag Sci; 2005 Nov; 8(4):253-65. PubMed ID: 16379409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis.
    Ortegon MM; Redekop WK; Niessen LW
    Diabetes Care; 2004 Apr; 27(4):901-7. PubMed ID: 15047646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Lower Extremity Nerve Decompression Surgery in the Prevention of Ulcers and Amputations: A Markov Analysis.
    Rinkel WD; Franks B; Birnie E; Castro Cabezas M; Coert JH
    Plast Reconstr Surg; 2021 Nov; 148(5):1135-1145. PubMed ID: 34705790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of illness attributable to diabetic foot and cost-effectiveness of secondary prevention in Peru.
    Cárdenas MK; Mirelman AJ; Galvin CJ; Lazo-Porras M; Pinto M; Miranda JJ; Gilman RH
    BMC Health Serv Res; 2015 Oct; 15():483. PubMed ID: 26503154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand.
    Permsuwan U; Chaiyakunapruk N; Dilokthornsakul P; Thavorn K; Saokaew S
    Appl Health Econ Health Policy; 2016 Jun; 14(3):281-92. PubMed ID: 26961276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of preventive screening programmes for type 2 diabetes mellitus in Germany.
    Schaufler TM; Wolff M
    Appl Health Econ Health Policy; 2010; 8(3):191-202. PubMed ID: 20408603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study].
    Köster I; Hauner H; von Ferber L
    Dtsch Med Wochenschr; 2006 Apr; 131(15):804-10. PubMed ID: 16607599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus and the St Vincent Declaration. The economic implications.
    Leese B
    Pharmacoeconomics; 1995 Apr; 7(4):292-307. PubMed ID: 10155319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calculation of the costs of drugs, medical materials, certain medical procedures and social services for patients with diabetic foot syndrome].
    Brunerová L; Andĕl M
    Vnitr Lek; 2003 Jun; 49(6):457-64. PubMed ID: 14503474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program.
    Neumann A; Lindholm L; Norberg M; Schoffer O; Klug SJ; Norström F
    Eur J Health Econ; 2017 Sep; 18(7):905-919. PubMed ID: 27913943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand.
    Blakely T; Kvizhinadze G; Karvonen T; Pearson AL; Smith M; Wilson N
    Vaccine; 2014 May; 32(22):2645-56. PubMed ID: 24662710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Illustration of Cost Saving Implications of Lower Extremity Nerve Decompression to Prevent Recurrence of Diabetic Foot Ulceration.
    Rankin TM; Miller JD; Gruessner AC; Nickerson DS
    J Diabetes Sci Technol; 2015 Jul; 9(4):873-80. PubMed ID: 26055081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
    Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
    Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
    Palmer AJ; Tucker DM
    Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
    Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
    Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.
    Stollenwerk B; Bartmus T; Klug F; Stock S; Müller D
    Osteoporos Int; 2015 Apr; 26(4):1367-79. PubMed ID: 25572047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of prevention and management of diabetic foot ulcer and amputation in a health resource-limited setting.
    Wu B; Wan X; Ma J
    J Diabetes; 2018 Apr; 10(4):320-327. PubMed ID: 28976723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model to analyse costs and benefit of intensified diabetic foot care in Austria.
    Habacher W; Rakovac I; Görzer E; Haas W; Gfrerer RJ; Wach P; Pieber TR
    J Eval Clin Pract; 2007 Dec; 13(6):906-12. PubMed ID: 18070261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.